Needham analyst Jack Andrews maintains C3.ai (NYSE:AI) with a Buy and lowers the price target from $146 to $122.
Jefferies Downgrades Forma Therapeutics Hldgs to Hold, Lowers Price Target to $20
Jefferies analyst Maury Raycroft downgrades Forma Therapeutics Hldgs (NASDAQ:FMTX) from Buy to Hold and lowers the price target from $28 to $20.